Christopher Peetz
CIK 1614740 · CHIEF EXECUTIVE OFFICER · last filed 2026-07-17
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$44.50M
Companies
4
Total Filings
62
Lifetime Open-Market Net
-$20.50M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ARQT | Director | 191,815 | $26.23 | $5.03M | $0 | 1 | 2026-07-17 |
| MIRM | CHIEF EXECUTIVE OFFICER | 401,809 | $98.23 | $39.47M | -$20.54M | 38 | 2026-07-08 |
| ALPINE IMMUNE SCIENCES, INC. (ALPN) Delisted | Director | 0 | $64.97 | $0 | $38.6K | 10 | 2024-05-20 |
| Tobira Therapeutics, Inc. (TBRA) Delisted | Chief Financial Officer | — | — | — | $0 | 3 | 2016-01-14 |
Recent Filings · Page 6 of 7
62 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-01-05 | ALPINE IMMUNE SCIENCES, INC. (ALPN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-12-28 | MIRM | Buy (P) | +5,000 | $93.5K | EDGAR |
| 2020-11-12 | MIRM | Grant (A) | +1,371 | $20.9K | EDGAR |
| 2020-01-14 | MIRM | Grant (A) | — | $0 | EDGAR |
| 2020-01-06 | ALPINE IMMUNE SCIENCES, INC. (ALPN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-09-10 | MIRM | Buy (P) | +9,070 | $99.9K | EDGAR |
| 2019-01-04 | ALPINE IMMUNE SCIENCES, INC. (ALPN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-04-24 | ALPINE IMMUNE SCIENCES, INC. (ALPN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-11-03 | — | Disp (D) | — | $0 | |
| 2016-01-14 | Tobira Therapeutics, Inc. (TBRA) Delisted | Grant (A) | — | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.